Z5D-14666-65800

2 vaccinations 6 coded responses 26 check-ins 6 free-text entries 3 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 840 / UT
Registered: 2020-12-29

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-29
Registered in v-safe
2020-12-29
Dose 1 — Moderna
2020-12-29
Health check-in — day 0, dose 1
Feeling: Good · Headache

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · None · Be unable to do your normal daily activities

Adult check-in
2020-12-30
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-31
Survey response — days 1–6 daily, dose 1
MedDRA: Erythema — Feeling: Good · Site: Pain, Redness, Swelling · Be unable to do your normal daily activities

Free text: Redness still expanding instead of diminishing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-31
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling, Itching · None

Adult check-in
2021-01-02
Survey response — days 1–6 daily, dose 1
MedDRA: Contusion — Feeling: Good · Site: Pain, Redness, Itching

Free text: Bruising

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-03
Survey response — days 1–6 daily, dose 1
MedDRA: Contusion, Rash — Feeling: Good · Site: Pain, Itching

Free text: Bruising on arm where rash extended

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-04
Survey response — days 1–6 daily, dose 1
MedDRA: Injection site bruising, Injection site swelling — Feeling: Good · Site: Itching

Free text: Bruising around swelling of site, diminishing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-05
Health check-in — day 7, dose 1
Feeling: Good · Site: Itching · Chills

Adult check-in
2021-01-12
Survey response — day 14, dose 1
MedDRA: Cellulitis, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling, Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Red welt and rash reappeared at injection site on day 8. Continued to grow, very uncomfortable and painful. Given antibiotics for concern of cellulitis. Did not improve by day13 (post injection). Given high regimen of antihistamine and h2 blocker

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-20
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-26
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-01-29
Dose 2 — Moderna
2021-01-29
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-30
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness · None

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Headache

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-05
Health check-in — day 7, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Call 1 — Left Voicemail
2021-02-26
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-02-28
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-13
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-30
Survey response — 3 months, dose 2
MedDRA: Injection site bruising, Pain — Feeling: Fair

Free text: Occasional soreness flares in 1st injection site with lifting weights/ heavy arm use. Bruising will reappear at site. This has happened twice.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-30
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-29
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-29	Moderna
2	2021-01-29	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2020-12-30	Successful	Reported to VAERS voluntarily prior to GDIT contact
2020-12-31	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-12	Successful 2021-02-26	Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-31

Systemic reaction (other): Redness still expanding instead of diminishing

2021-01-02

Systemic reaction (other): Bruising

2021-01-03

Systemic reaction (other): Bruising on arm where rash extended

2021-01-04

Systemic reaction (other): Bruising around swelling of site, diminishing

Release 1 — day 14, dose 1

2021-01-12

Symptoms: Red welt and rash reappeared at injection site on day 8. Continued to grow, very uncomfortable and painful. Given antibiotics for concern of cellulitis. Did not improve by day13 (post injection). Given high regimen of antihistamine and h2 blocker

Release 8 — 3 months, dose 2

2021-04-30

Symptoms: Occasional soreness flares in 1st injection site with lifting weights/ heavy arm use. Bruising will reappear at site. This has happened twice.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cellulitis	✓	✓	✓
SD	Injection site bruising	✓	✓	✓
SD	Injection site erythema	✓	✓	✓
SD	Injection site pain	✓	✓	✓
SD	Injection site rash	✓	✓	✓
SD	Injection site swelling	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Urticaria	✓	✓	✓
SRO	Contusion	✓	✓	✓
SRO	Erythema	✓	✓	✓
SRO	Injection site bruising	✓	✓	✓
SRO	Injection site swelling	✓	✓	✓
SRO	Rash	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release